These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10862524)

  • 21. DRD2 genotypic and haplotype variation is associated with improvements in negative symptoms after 6 weeks' amisulpride treatment.
    Kang SG; Na KS; Lee HJ; Chee IS; Lee K; Lee J
    J Clin Psychopharmacol; 2015 Apr; 35(2):158-62. PubMed ID: 25679126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group.
    Kramer MS; Last B; Getson A; Reines SA
    Arch Gen Psychiatry; 1997 Jun; 54(6):567-72. PubMed ID: 9193198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D2 receptor genotype is associated with increased mortality at a 10-year follow-up of alcohol-dependent individuals.
    Berggren U; Fahlke C; Berglund KJ; Wadell K; Zetterberg H; Blennow K; Thelle D; Balldin J
    Alcohol Alcohol; 2010; 45(1):1-5. PubMed ID: 19654188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients.
    Shen YC; Chen SF; Chen CH; Lin CC; Chen SJ; Chen YJ; Luu SU
    J Psychiatr Res; 2009 Mar; 43(6):600-6. PubMed ID: 18926547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolactin levels in antipsychotic treatment of patients with schizophrenia carrying the DRD2*A1 allele.
    Young RM; Lawford BR; Barnes M; Burton SC; Ritchie T; Ward WK; Noble EP
    Br J Psychiatry; 2004 Aug; 185():147-51. PubMed ID: 15286066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of the TaqI A polymorphism of the dopamine D(2) receptor gene with predisposition to neuroleptic malignant syndrome.
    Suzuki A; Kondo T; Otani K; Mihara K; Yasui-Furukori N; Sano A; Koshiro K; Kaneko S
    Am J Psychiatry; 2001 Oct; 158(10):1714-6. PubMed ID: 11579007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The A1 allele of the D2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics.
    Laine TP; Ahonen A; Räsänen P; Pohjalainen T; Tiihonen J; Hietala J
    Alcohol Alcohol; 2001; 36(3):262-5. PubMed ID: 11373265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function.
    Lane HY; Lee CC; Chang YC; Lu CT; Huang CH; Chang WH
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):461-70. PubMed ID: 15140279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing the influence of dopamine D₂ polymorphisms and plasma drug concentrations on the clinical response to risperidone.
    Yasui-Furukori N; Tsuchimine S; Saito M; Nakagami T; Sugawara N; Fujii A; Kaneko S
    J Clin Psychopharmacol; 2011 Oct; 31(5):633-7. PubMed ID: 21869689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between multidrug resistance 1 (MDR1) gene polymorphisms and therapeutic response to bromperidol in schizophrenic patients: a preliminary study.
    Yasui-Furukori N; Saito M; Nakagami T; Kaneda A; Tateishi T; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):286-91. PubMed ID: 16386826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine DRD2 Taq I polymorphism associates with caudate nucleus volume and cognitive performance in memory impaired subjects.
    Bartrés-Faz D; Junqué C; Serra-Grabulosa JM; López-Alomar A; Moya A; Bargalló N; Mercader JM; Moral P; Clemente IC
    Neuroreport; 2002 Jul; 13(9):1121-5. PubMed ID: 12151753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?
    David SP; Niaura R; Papandonatos GD; Shadel WG; Burkholder GJ; Britt DM; Day A; Stumpff J; Hutchison K; Murphy M; Johnstone E; Griffiths SE; Walton RT
    Nicotine Tob Res; 2003 Dec; 5(6):935-42. PubMed ID: 14668077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of the DRD2 TaqIA polymorphism with impulsivity and substance use: preliminary results from a clinical sample of adolescents.
    Esposito-Smythers C; Spirito A; Rizzo C; McGeary JE; Knopik VS
    Pharmacol Biochem Behav; 2009 Sep; 93(3):306-12. PubMed ID: 19344737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of association in Japanese patients between neuroleptic malignant syndrome and the TaqI A polymorphism of the dopamine D2 receptor gene.
    Kishida I; Kawanishi C; Furuno T; Matsumura T; Hasegawa H; Sugiyama N; Suzuki K; Yamada Y; Kosaka K
    Psychiatr Genet; 2003 Mar; 13(1):55-7. PubMed ID: 12605103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients.
    Xing Q; Qian X; Li H; Wong S; Wu S; Feng G; Duan S; Xu M; Gao R; Qin W; Gao J; Meng J; He L
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):631-7. PubMed ID: 17105675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association analysis for dopamine D2 receptor Taq1 polymorphism with P300 event-related potential for normal young females.
    Lin CH; Yu YW; Chen TJ; Tsa SJ; Hong CJ
    Psychiatr Genet; 2001 Sep; 11(3):165-8. PubMed ID: 11702060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic predisposition in alcoholism: association of the D2 dopamine receptor TaqI B1 RFLP with severe alcoholics.
    Blum K; Noble EP; Sheridan PJ; Montgomery A; Ritchie T; Ozkaragoz T; Fitch RJ; Wood R; Finley O; Sadlack F
    Alcohol; 1993; 10(1):59-67. PubMed ID: 8095394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients.
    Gunes A; Scordo MG; Jaanson P; Dahl ML
    Psychopharmacology (Berl); 2007 Mar; 190(4):479-84. PubMed ID: 17102980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alcoholics with the dopamine receptor DRD2 A1 allele have lower platelet monoamine oxidase-B activity than those with the A2 allele: a preliminary study.
    Eriksson M; Berggren U; Blennow K; Fahlke C; Månsson JE; Balldin J
    Alcohol Alcohol; 2000; 35(5):493-8. PubMed ID: 11022024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status.
    Eisenstein SA; Bogdan R; Love-Gregory L; Corral-Frías NS; Koller JM; Black KJ; Moerlein SM; Perlmutter JS; Barch DM; Hershey T
    Synapse; 2016 Oct; 70(10):418-31. PubMed ID: 27241797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.